Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Brendan Coffey - Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027?
Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027?
The Motley Fool –

As the global health landscape shifts toward obesity treatments, investors are weighing the rapid growth of Novo Nordisk A/S (NVO +2.41%) against the deep-rooted stability of Pfizer Inc. (PFE +0.21%) to determine the better long-term choice. Novo…

marketbeat.com - Wall Street Zen Upgrades Avalyn Pharma (NASDAQ:AVLN) to Hold
Wall Street Zen Upgrades Avalyn Pharma (NASDAQ:AVLN) to Hold
MarketBeat –

Avalyn Pharma (NASDAQ:AVLN - Get Free Report) was upgraded by research analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a note issued to investors on Saturday, Wall Street Zen reports. AVLN has been the topic of several other…

marketbeat.com - Spyglass Pharma (NASDAQ:SGP) Price Target Raised to $45.00
Spyglass Pharma (NASDAQ:SGP) Price Target Raised to $45.00
MarketBeat –

Spyglass Pharma (NASDAQ:SGP - Get Free Report) had its price objective hoisted by research analysts at Citigroup from $42.00 to $45.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a 'buy' rating on…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Stock Rating Upgraded by Wall Street Zen
Royalty Pharma (NASDAQ:RPRX) Stock Rating Upgraded by Wall Street Zen
MarketBeat –

Royalty Pharma (NASDAQ:RPRX - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a 'buy' rating to a 'strong-buy' rating in a report issued on Saturday, Wall Street Zen reports. How Royalty Pharma Prints Cash Without…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $91.00
BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $91.00
MarketBeat –

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price raised by investment analysts at Morgan Stanley from $88.00 to $91.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an 'overweight' rating on…

elizabethnickson.substack.com - elizabeth nickson - Did The Israel and Pharma Lobbies Queer the Trump Presidency?
Did The Israel and Pharma Lobbies Queer the Trump Presidency?
Welcome to Absurdistan –

Calley Means, that slight, dark, fierce intellect who sat at Bobby Kennedy's right hand for the past two years let off a delicious fusillade of shots last week, which wounded then killed off Susie Wiles, Trump's Chief of Staff and her team. It was…

mirror.co.uk - Daniel Bird - Liverpool Hall of Fame statement in full as Ian McNabb's induction axed
Liverpool Hall of Fame statement in full as Ian McNabb's induction axed
Daily Mirror –

Ian McNabb's induction into the Liverpool Legends Hall of Fame has been axed. It comes after the musician, the former frontman of The Icicle Works, defended convicted rapist Russell Brand. The Hall of Fame, established at Liverpool's Beatles…

seekingalpha.com - Albert Anthony - Principal Financial: Still Bullish After Stellar Q3 Results, With Retirement Niche In Focus
Principal Financial: Still Bullish After Stellar Q3 Results, With Retirement Niche In Focus
Seeking Alpha –

Principal Financial earns a reiterated buy rating, supported by strong market momentum, robust credit ratings, and a diversified, innovative platform. PFG's Q3 results highlight organic growth in retirement and benefits segments, with operating EPS…

fastcompany.com - Sarah Hofmann - Pharmaceutical ads may influence which drug AI recommends, new research finds
Pharmaceutical ads may influence which drug AI recommends, new research finds
Fast Company –

Next time you ask AI for medical advice, you may want to consider whether it's been influenced by Big Pharma. Prescription drug advertisements are everywhere, and may affect AI's recommendations, according to a study published in The Lancet Digital…

thehindu.com -  PTI - Comply with new prices of 137 anti-cancer drugs or face action, says regulator
Comply with new prices of 137 anti-cancer drugs or face action, says regulator
The Hindu –

The National Pharmaceutical Pricing Authority (NPPA) has warned of penal action against those failing to comply with the revised prices of 137 non-scheduled anti-cancer drugs The authority, which functions under the Department of Pharmaceuticals…

fool.com - Adria Cimino - Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech?
Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech?
The Motley Fool –

Commercial-stage biotech companies make great investments for those of us looking for both safety and growth. Their portfolios of commercialized products offer a certain degree of revenue stability since patients always need their medicines…

fool.com - Keith Speights - Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?
The Motley Fool –

Pfizer (PFE +0.21%) and AbbVie (ABBV +0.20%) rank among the biggest drugmakers in the world. Both pharma stocks have also been favorites for many income investors through the years. However, Pfizer and AbbVie offer distinctly different attractions…

indianexpress.com - Anagha Jayakumar - How hackers took control of supermarket fridges across Europe, and what it means for India's cold chain
How hackers took control of supermarket fridges across Europe, and what it means for India's cold chain
The Indian Express –

On November 9, France accused Shahid Kaveh, a unit linked to Iran's Revolutionary Guard Corps (IRGC), of orchestrating the October attacks, a charge Iran has denied. Authorities have not established that the subsequent incidents were carried out by…

lesswrong.com - I was Zohran's campaign manager. Here's what the AI safety community can learn from the populist left. - LessWrong
I was Zohran's campaign manager. Here's what the AI safety community can learn from the populist left. - LessWrong
Transformative AI –

After a couple of years working in data and tech at GiveDirectly, I left to work in politics, campaigning for candidates at the state, local, and federal levels. I most recently managed Mayor Zohran Mamdani's general election campaign, but earlier…

heraldscotland.com - Hannah Brown - UK ministers admit no talks with Scotland on impact of Trump's NHS drugs deal
UK ministers admit no talks with Scotland on impact of Trump's NHS drugs deal
The Herald –

However, the UK Government has rejected suggestions that Scotland could face billions of pounds in additional costs, saying the estimates do not reflect its own assessment. The deal, agreed between the UK and US governments in December last year…

Receive a Daily briefing on Pharma Industry News

Get Started